Nationwide Fund Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-510,438
Closed -$45.4M 15
2017
Q3
$45.4M Sell
510,438
-16,482
-3% -$1.25M 0.18% 94
2017
Q2
$38.2M Sell
526,920
-30,999
-6% -$2.08M 0.15% 116
2017
Q1
$36.4M Sell
557,919
-155,753
-22% -$9.79M 0.15% 133
2016
Q4
$44.7M Sell
713,672
-263,414
-27% -$16.1M 0.19% 91
2016
Q3
$61.6M Buy
977,086
+370,993
+61% +$24M 0.26% 50
2016
Q2
$37.5M Sell
606,093
-917,120
-60% -$55.9M 0.16% 116
2016
Q1
$87M Buy
1,523,213
+612,504
+67% +$34.1M 0.38% 31
2015
Q4
$54M Sell
910,709
-144,968
-14% -$8.35M 0.23% 71
2015
Q3
$57.4M Sell
1,055,677
-7,997
-0.8% -$521K 0.26% 67
2015
Q2
$71.5M Buy
1,063,674
+417,641
+65% +$27.3M 0.29% 52
2015
Q1
$37.8M Sell
646,033
-127,792
-17% -$7.72M 0.15% 132
2014
Q4
$50.6M Sell
773,825
-57,193
-7% -$3.61M 0.22% 82
2014
Q3
$48M Sell
831,018
-202,316
-20% -$11.2M 0.2% 86
2014
Q2
$58.3M Buy
1,033,334
+71,473
+7% +$3.75M 0.24% 70
2014
Q1
$49.4M Sell
961,861
-49,928
-5% -$2.52M 0.23% 81
2013
Q4
$53.4M Buy
1,011,789
+37,843
+4% +$1.86M 0.22% 85
2013
Q3
$43.6M Sell
973,946
-69,353
-7% -$3.07M 0.2% 100
2013
Q2
$43.1M Buy
+1,043,299
New +$45.6M 0.23% 73

Other funds holding ABBV

Nationwide Fund Advisors's ABBV Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 510,438 shares — an estimated $45.4M sold.

Nationwide Fund Advisors first reported a position in ABBV in Q2 2013 and held it in 18 quarters. The position peaked at $87M in Q1 2016. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 510,438 AbbVie shares in Q4 2017, an estimated $45.4M.
  • Nationwide Fund Advisors first reported a position in AbbVie in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's AbbVie position peaked at $87M in Q1 2016.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.